← Leaderboards
Fangming Zuo
Inotek Pharmaceuticals Corporation
$1,288,390
Attributed
$1,288,390
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,288,390 · 2
By mechanism
R44$916,102 · 1
R43$372,288 · 1
Top collaborators
No co-investigators on record.
Most similar at Inotek Pharmaceuticals Corporation
Same institution · by research overlap
- Csaba Szabo$15,264,870
- Andrew L Salzman$19,918,828
- Jon G Mabley$947,474
- Garry John Southan$13,828,224
- Ludmila Belayev$1,038,850
Others in their field
Top investigators on “Pharmacokinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$237,100,725
- Constance Ann Benson · University Of California, San Diego$151,891,628
- Richard L Schilsky · University Of Chicago$114,474,127
- Ronald T Mitsuyasu · University Of California Los Angeles$105,970,100
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,574,471
- Myron S Cohen · Family Health International$91,263,426
Research focus
PharmacokineticsEnzyme InhibitorsDrug Screening /EvaluationPentosyltransferaseDental Disorder ChemotherapyDiabetic NeuropathyDogsDrug Design /Synthesis /ProductionDrug WithdrawalElectrostimulusEnzyme ActivityGingiva DisorderGuanidinesHigh Performance Liquid ChromatographyImmunocytochemistryLaboratory RatLiquid Chromatography Mass SpectrometryMedical ComplicationMolecular PathologyMorphometryNeurophysiologyNonhuman Therapy EvaluationNuclear Magnetic Resonance SpectroscopyOxidative Stress